Mainz Biomed B.V.
MYNZ | NASDAQ
$3.59
+$0.03 (+0.84%)
At close: May 22, 2026, 12:35 PM ET
+0.84%
(1D)No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Market Cap $14.69M
1D Range
3.38 3.72
52W Range
0.55 5.34
Valuation (TTM)
PE -3.42
PB 0.72
EV/EBITDA -0.09
Valuation (NTM)
Forward PE N/A
Forward PEG 0.04
Price Target N/A
Cash Flow
FCF Yield -68.3%
SBC Adj. FCF Yield -114.3%
SBC Impact -67.4%
Margins
Gross Margin 33.7%
Operating Margin -6109.7%
FCF Margin -4008.0%
Growth (CAGR)
Revenue 3Y | 5Y -7.6% |
1.7%
Dil EPS 3Y | 5Y 5.3% |
-37.3%
FCF 3Y | 5Y -1.0% |
-12.3%
Returns
ROA -80.8%
ROE -179.8%
ROIC -75.1%
Financial Health
Net Cash
$13.38M
Current Ratio 5.56
Interest Coverage 683.39
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Mainz Biomed B.V. is a German company specializing in molecular genetics for the development of cancer diagnostics. The firm engineers both in-vitro diagnostic (IVD) tools and assays designed exclusiv...
Sector Healthcare
Industry Medical - Diagnostics & Research
Employees 19
IPO Date Nov 5, 2021
Website quantum-cyber.ai
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove MYNZ